These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000919-26 Phase II, randomized, pharmokinetic, dose finding, and dose frequency determination using rt-PA in intraventricular hemorrhage 2008-08-21 due-trials
Completed, but no date, and reported results 2004-001622-24 Phase III,multicentre,open-label,prospective randomised trial comparing Imatinib alone at 400mg versus 800mg daily versus Imatinib 400mg daily plus PEG Interferon-alpha with newly diagnosed chronic my... bad-data
Reported results 2004-002262-37 Adenosine testing in the diagnosis of unexplained syncope: A pilot study 2005-10-31 due-trials
Reported results 2004-002427-40 What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin? 2008-10-10 due-trials
Reported results Terminated 2004-002482-20 A Pilot Study to Test the Effect of Treating Depression Associated with Rueumatoid Arthritis (RA) using Venlaflaxine 2007-10-16 due-trials
Reported results 2004-004874-96 Protocol: HL/IDP/PTS/001 Tumour Profiling In An Open-Labelled, 2-Arm Study Investigating The Tolerability And Efficacy Of Taxotere In Patients With High Risk Prostate Cancer 2010-08-20 due-trials
Reported results 2004-004884-31 An open label, randomized pilot study evaluating the early conversion from calcineurin inhibitors to Rapamune in patients with impaired renal function following kidney transplantation 2007-07-01 due-trials
Reported results 2005-000707-34 The induction of apoptosis by anti-psoriatic treatments 2013-12-30 due-trials
Reported results 2005-001007-18 Reversal of warfarin anticoagulation with oral vitamin K: towards a better management of over-anticoagulation 2009-03-15 due-trials
Not reported 2005-003903-35 : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis 2009-07-31 due-trials
Other 2005-004126-56 Observational pharmacokinetic study of doxorubicin and cyclophosphamide in patients with early breast cancer. not-yet-due
Reported results 2006-000485-36 A randomised, double blind, placebo controlled study to Assess The Effect of Antibiotic Therapy on Chronic Rejection in Human Lung Transplantation 2011-03-31 due-trials
Reported results 2006-001265-41 A comparison of Sirolimus versus Tacrolimus as a delayed treatment of recipients of non heart beating donor kidneys after anti-IL2 monoclonal antibody 2010-03-31 due-trials
Other 2006-001774-24 INTESTINAL MICRO-ORGANISMS IN THE PATHOGENESIS OF NASH AND THE ROLE OF MODULATION OF ENTERIC BACTERIA IN TREATMENT. not-yet-due
Reported results 2006-002042-11 “The efficacy of inferior alveolar nerve block and buccal infiltration for pulp anaesthesia in mandibular teeth” 2007-02-02 due-trials
Reported results 2006-002047-92 A multicentre, open-label, randomized comparison of once daily insulin detemir given pre-breakfast or bedtime, according to need, with bedtime insulin glargine in people with type 2 diabetes character... 2010-04-28 due-trials
Not reported 2006-002532-24 Pharmacogenetic study of FcγRIIIa and HER2 genes in relation to treatment of breast cancer 2013-08-15 due-trials
Reported results 2006-002845-36 Pharmacokinetics and pharmacogenetics of anticancer drugs in infants and young children 2014-09-12 due-trials
Reported results 2006-003745-16 Assessment of platelet-dependent thrombosis by an ex vivo arterial injury model: a placebo controlled trial of Clopidogrel as antiplatelet therapy in patients with type 2 diabetes mellitus and coronar... 2011-08-31 due-trials
Reported results 2006-004335-29 A randomised controlled factorial pilot study investigating Omacor and/or Fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti-viral therapy. 2010-04-26 due-trials
Reported results 2006-006127-40 Cerebral Blood Flow following TNF-alpha Antagonism in Rheumatoid Arthritis - a Pilot Study 2009-03-31 due-trials
Reported results 2006-007056-18 The Discoid Lupus Research Project 2010-05-17 due-trials
Reported results 2007-002357-23 An open label, randomized 2 part crossover study to investigate the effect of buprenorphine transdermal delivery system (BTDS) compared with co-codamol on physical activity in subjects aged 60 years o... 2009-12-29 due-trials
Reported results 2007-002899-34 Pilot Controlled Clinical Trial of Salvia Officinalis (Sage) for cognitive impairments in Parkinson's Disease 2008-08-31 due-trials
Reported results 2007-003062-18 Immunotherapeutic Rescue of steroidogenic function in autoimmune Addison’s Disease (RAD): Pilot study 2011-05-05 due-trials
Reported results 2007-005932-10 A double-blind randomised multi-centre, placebo-controlled trial of combined ACE-inhibitor and beta-blocker therapy in preventing the development of cardiomyopathy in genetically characterised males w... 2018-03-23 due-trials
Reported results 2007-006006-22 Minimally Invasive Surgery plus rt-PA for ICH Evacuation 2014-09-02 due-trials
Reported results 2007-006185-15 STI571 Prospective International RandomIsed Trial 2 - A phase III, prospective randomised comparison of imatinib (STI571, Glivec/Gleevec) 400mg daily versus dasatinib (Sprycel) 100mg daily in patient... 2018-03-07 due-trials
Reported results 2008-000224-27 Systemic sclerosis associated interstitial lung disease: A longitudinal observational study assessing optimum treatment regimens. 2011-07-31 due-trials
Reported results 2008-003606-33 Pilot study to investigate the feasibility of 13-cis-Retinoic acid pharmacokinetic monitoring in high-risk neuroblastoma 2015-05-13 due-trials
Reported results 2008-005395-27 Inter-individual variability in response to warfarin in children: Analysis of environmental and pharmacogenetic factors 2011-02-07 due-trials
Reported results Terminated 2008-006238-87 Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K 2012-11-15 due-trials
Reported results Terminated 2008-006451-52 An investigation of the association between vitamin K intake, vitamin K epoxide reductase subunit (VKORC1) genotype and anticoagulation response to warfarin 2012-03-14 due-trials
Reported results 2009-015166-62 A randomised controlled trial of Losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. 2014-12-31 due-trials
Reported results Terminated 2009-015170-35 Multicentre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated with Parkinson's Disease (MUSTARDD-PD) 2014-09-01 due-trials
Reported results 2009-015396-27 Prevention of Recurrent Severe Hypoglycaemia: a Definitive RCT Comparing Optimised MDI and CSII with or without Adjunctive Real-time Continuous Glucose Monitoring. 2013-10-03 due-trials
Reported results 2009-018074-56 Revival of autochthonous adrenocortical stem cells in autoimmune Addison’s disease (RoSA) 2012-09-14 due-trials
Reported results 2010-019180-10 Paramedic Initiated Lisinopril For Acute Stroke Treatment(PIL-FAST): A Pilot Randomised Controlled Trial 2011-12-17 due-trials
Reported results 2010-021146-22 Alemtuzumab and rheumatoid arthritis - an immunisation study 2014-11-20 due-trials
Reported results 2011-000608-16 To evaluate the safety and effectiveness of human ex vivo expanded autologous limbal stem cells for the treatment of unilateral total limbal stem cell deficiency 2018-02-09 due-trials
Reported results 2011-004425-27 Study of Optimal Replacement of Thyroxine in the ElDerly (SORTED) SORTED 1 – a Randomised Controlled Trial (Pilot study) SORTED 2 – Qualitative Interviews SORTED 3 – Retrospective Cohort 2014-10-15 due-trials
Reported results 2011-004890-10 Optimising Vitamin D Status in Older People: A Randomised Controlled Trial of Vitamin D Supplementation 2014-06-05 due-trials
Exempt, with results Terminated 2011-005318-12 Phase 1 study of use of 5% Carbogen in treatment of paediatric non-convulsive status epilepticus 2015-01-12 not-yet-due
Reported results 2011-005581-37 Efficacy of Switch to Lopinavir/Ritonavir in Improving Cognitive function in Efavirenz treated patients 2014-12-31 due-trials
Exempt, with results 2011-005815-10 Developmental Clinical Sciences: Does GM-CSF restore effective neutrophil function in critically ill patients? 2015-02-12 not-yet-due
Reported results Terminated 2012-000145-12 Rituximab for the Treatment of Fatigue in Primary Biliary Cirrhosis (PBC) 2016-09-12 due-trials
Reported results 2012-001682-33 Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison’s Disease 2016-08-16 due-trials
Reported results Terminated 2012-005696-14 A phase 3 randomised non-inferiority trial to evaluate the use of imatinib, nilotinib and ponatinib in patients with newly-diagnosed chronic phase chronic myeloid leukaemia 2016-09-16 due-trials
Other 2013-000052-17 Pilot study to investigate the early prediction of toxicity following induction chemotherapy in Ewing’s sarcoma by blood-borne biomarkers and correlation with age-dependent pharmacokinetic variation not-yet-due
Reported results 2013-000863-94 A single blind study comparing the efficacy of Glycopyrronium and Hyoscine on drooling in children with neurodisability - DRI Trial (Drooling Reduction Intervention) 2017-01-31 due-trials
Reported results 2013-002556-32 Antibiotic treatment for intermittent bladder catheterisation: A randomised controlled trial of once daily prophylaxis (The AnTIC study) 2017-02-23 due-trials
Reported results 2013-003301-26 A randomised placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis (IPF) 2016-09-27 due-trials
Reported results 2013-004249-17 A randomised, placebo controlled trial of extra-oesophageal reflux treatment in the management of upper respiratory symptoms. [TOPPITS: Trial of Proton Pump Inhibitors in Throat Symptoms] 2018-03-23 due-trials
Other 2014-000411-14 A randomised double blind dose non-inferiority trial of a daily dose of 600mg versus 300mg versus 100mg of enteric coated aspirin as a cancer preventive in carriers of a germline pathological mismatch... not-yet-due
Not reported 2014-001008-23 Riociguat in patients with respiratory disease and hypoxia – a proof-of-concept study 2016-08-23 due-trials
Exempt, with results 2014-001342-21 Topical tropomysin kinase (TRK) inhibitor as a treatment for inherited CYLD defective skin tumours (TRAC) 2016-07-31 not-yet-due
Reported results 2014-002628-29 Evaluating the effectiveness of intravenous ciclosporin on reducing reperfusion injury in patients undergoing primary percutaneous coronary intervention: a double-blind, phase II, randomised controlle... 2017-11-11 due-trials
Reported results 2014-004249-29 An Open Label, Non-Randomised, Phase II study to Determine if Dabigatran and its Metabolites are Detectable in Breast Milk Following Oral Administration to Non-Breastfeeding Mothers 2016-12-31 due-trials
Reported results 2014-005475-86 Anti-platelet Therapy in the Primary Prevention of Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease. 2017-11-10 due-trials
Reported results 2015-000508-24 A Feasibility Study of Bezafibrate in Mitochondrial Myopathy 2017-03-23 due-trials
Reported results 2015-003195-68 Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne Muscular Dystrophy. 2019-03-04 due-trials
Reported results 2015-003487-36 Alternatives to prophylactic antibiotics for the treatment of recurrent urinary tract infection in women 2020-01-27 due-trials
Reported results 2016-000209-35 Adjuvant rituximab – a potential treatment for the young patient with Graves’ hyperthyroidism 2020-08-27 due-trials
Other 2016-000997-39 Eculizumab in Shiga-Toxin producing E. Coli Haemolytic Uraemic Syndrome (ECUSTEC): A Randomised, Double-Blind, Placebo-Controlled Trial not-yet-due
Other 2017-000893-12 Nasal Airway Obstruction Study not-yet-due
Reported results 2017-001651-31 EMPOWER: EMesis in Pregnancy - Ondansetron With mEtoclopRamide. 2020-04-02 due-trials
Other 2017-003916-37 Multicentre, open label, prospective, single arm study of the safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome not-yet-due
Exempt 2018-002633-38 An open label phase I/IIa trial repurposing carbamazepine (CBZ) for the treatment of skeletal dysplasia in children. not-yet-due
Other 2018-002721-29 Randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in patients with Mitochondrial Myopathy not-yet-due